Anthropometric factors and endometrial cancer risk: A systematic review and dose-response meta-analysis of prospective studies

Annals of Oncology

Volumn 26, Issue 8, 2015, Pages 1635-1648

  Aune, Dagfinn ^a,b   Navarro Rosenblatt, D A ^a   Chan, D S M ^a   Vingeliene, S ^a   Abar, L ^a   Vieira, A R ^a   Greenwood, D C ^c   Bandera, E V ^d,e   Norat, T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Body mass index; Endometrial cancer; Height; Meta analysis; Waist circumference; Waist to hip ratio

Indexed keywords

ABDOMINAL FAT; ADULT; ANTHROPOMETRIC PARAMETERS; BODY HEIGHT; BODY MASS; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DOSE RESPONSE; ENDOMETRIUM CANCER; FEMALE; HIP CIRCUMFERENCE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; META ANALYSIS; OBESITY; PARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN; ANTHROPOMETRY; ENDOMETRIAL NEOPLASMS; OBESITY, ABDOMINAL; OVERWEIGHT; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ANTHROPOMETRY; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY; OBESITY, ABDOMINAL; OVERWEIGHT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84938394385     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv142     Document Type: Review

References (91)

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-386.
2. Matsuda T, Marugame T, Kamo K et al. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011; 41: 139-147.
3. Huang CY, Chen CA, Chen YL et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PLoS One 2012; 7: e51372.
4. Tornberg SA, Carstensen JM. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer 1994; 69: 358-361.
5. de Waard F, de Ridder CM, Baanders-van Halewyn EA, Slotboom BJ. Endometrial cancer in a cohort screened for breast cancer. Eur J Cancer Prev 1996; 5: 99-104.
6. Tulinius H, Sigfusson N, Sigvaldason H et al. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997; 6: 863-873.
7. Folsom AR, Demissie Z, Harnack L. Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa women's health study. Nutr Cancer 2003; 46: 119-124.
8. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004; 96: 1635-1638.
9. Silvera SA, Rohan TE, Jain M et al. Glycaemic index, glycaemic load and risk of endometrial cancer: a prospective cohort study. Public Health Nutr 2005; 8: 912-919.
10. Lacey JV, Jr, Brinton LA, Lubin JH et al. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1724-1731.
11. Rapp K, Schroeder J, Klenk J et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005; 93: 1062-1067.
12. Kuriyama S, Tsubono Y, Hozawa A et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-157.
13. Lukanova A, Bjor O, Kaaks R et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006; 118: 458-466.
14. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR, 2007.
15. Jonsson F, Wolk A, Pedersen NL et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 2003; 106: 594-599.
16. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003; 104: 669-676.
17. Bjorge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 2007; 120: 378-383.
18. Lof M, Sandin S, Hilakivi-Clarke L, Weiderpass E. Birth weight in relation to endometrial and breast cancer risks in Swedish women. Br J Cancer 2007; 96: 134-136.
19. Reeves GK, Pirie K, Beral V et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
20. Friedenreich C, Cust A, Lahmann PH et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 2007; 18: 399-413.
21. Chang SC, Lacey JV, Jr, Brinton LA et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2007; 16: 723-730.
22. Lundqvist E, Kaprio J, Verkasalo PK et al. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 2007; 121: 810-818.
23. Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 2008; 26: 3395-3402.
24. McCullough ML, Patel AV, Patel R et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 2008; 17: 73-79.
25. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008; 98: 1582-1585.
26. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer 2009; 124: 2938-2941.
27. Epstein E, Lindqvist PG, Geppert B, Olsson H. A population-based cohort study on sun habits and endometrial cancer. Br J Cancer 2009; 101: 537-540.
28. Conroy MB, Sattelmair JR, Cook NR et al. Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control 2009; 20: 1107-1115.
29. Canchola AJ, Chang ET, Bernstein L et al. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 2010; 21: 1407-1416.
30. Reeves KW, Carter GC, Rodabough RJ et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol 2011; 121: 376-382.
31. Park SL, Goodman MT, Zhang ZF et al. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer 2010; 126: 490-499.
32. Sung J, Song YM, Lawlor DA et al. Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol 2009; 170: 53-64.
33. Green J, Cairns BJ, Casabonne D et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011; 12: 785-794.
34. Kabat GC, Heo M, Kamensky V et al. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 2013; 132: 1125-1132.
35. Kabat GC, Anderson ML, Heo M et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2013; 22: 1353-1363.
36. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
37. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
38. Crosbie EJ, Zwahlen M, Kitchener HC et al. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 3119-3130.
39. Yang TY, Cairns BJ, Allen N et al. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer 2012; 107: 169-175.
40. Bhaskaran K, Douglas I, Forbes H et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: 755-765.
41. Han X, Stevens J, Truesdale KP et al. Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer 2014; 135: 2900-2909.
42. Wu MM, Chen HC, Chen CL et al. A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels. PLoS One 2014; 9: e104630.
43. Weiderpass E, Sandin S, Lof M et al. Endometrial cancer in relation to coffee, tea, and caffeine consumption: a prospective cohort study among middle-aged women in Sweden. Nutr Cancer 2014; 66: 1132-1143.
44. Alford SH, Rattan R, Buekers TE, Munkarah AR. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Cancer 2015; 121: 441-447.
45. Dougan MM, Hankinson SE, Vivo I et al. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer 2015 Jan 13 [epub ahead of print], doi: 10.1002/ijc.29427.
46. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
47. Khan M, Mori M, Sakauchi F et al. Risk of endometrial cancer mortality by everuse of sex hormones and other factors in Japan. Asian Pac J Cancer Prev 2006; 7: 260-266.
48. Gapstur SM, Potter JD, Sellers TA et al. Alcohol consumption and postmenopausal endometrial cancer: results from the Iowa Women's Health Study. Cancer Causes Control 1993; 4: 323-329.
49. Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res 1989; 49: 6828-6831.
50. Terry P, Baron JA, Weiderpass E et al. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 1999; 82: 38-42.
51. Folsom AR, Kushi LH, Anderson KE et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 2000; 160: 2117-2128.
52. Kabat GC, Kim MY, Hollenbeck AR, Rohan TE. Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 2014; 25: 1697-1706.
53. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
54. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
55. Aune D, Greenwood DC, Chan DS et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response metaanalysis of prospective studies. Ann Oncol 2012; 23: 843-852.
56. Chene G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996; 144: 610-621.
57. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008; 27: 954-970.
58. Bagnardi V, Zambon A, Quatto P, Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 2004; 159: 1077-1086.
59. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
60. Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (13 August 2014, date last accessed).
61. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
62. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
63. Keum N, Greenwood DC, Lee DH et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015 Mar 10; 107 (2): doi:10.1093/jnci/djv088.
64. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531-1543.
65. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996; 88: 756-758.
66. Kaye SA, Folsom AR, Soler JT et al. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991; 20: 151-156.
67. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-1226.
68. Allen NE, Key TJ, Dossus L et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008; 15: 485-497.
69. Abdullah A, Peeters A, de Court M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a metaanalysis of prospective cohort studies. Diabetes Res Clin Pract 2010; 89: 309-319.
70. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-1374.
71. Bjorge T, Stocks T, Lukanova A et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892-902.
72. Cust AE, Kaaks R, Friedenreich C et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007; 14: 755-767.
73. Huang Y, Cai X, Qiu M et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 2014; 57: 2261-2269.
74. Lukanova A, Zeleniuch-Jacquotte A, Lundin E et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 and risk of endometrial cancer. Int J Cancer 2004; 108: 262-268.
75. Cust AE, Allen NE, Rinaldi S et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 2007; 120: 2656-2664.
76. Esposito K, Chiodini P, Capuano A et al. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine 2014; 45: 28-36.
77. Grady D, Gebretsadik T, Kerlikowske K et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-313.
78. Aune D, Vieira AR, Chan DS et al. Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes Control 2012; 23: 1213-1222.
79. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulinlike growth factor-I. Proc Nutr Soc 2001; 60: 91-106.
80. Gunter MJ, Hoover DR, Yu H et al. A prospective evaluation of insulin and insulinlike growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 921-929.
81. Weiderpass E, Brismar K, Bellocco R et al. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 2003; 89: 1697-1704.
82. Petridou E, Koukoulomatis P, Alexe DM et al. Endometrial cancer and the IGF system: a case-control study in Greece. Oncology 2003; 64: 341-345.
83. Oh JC, Wu W, Tortolero-Luna G et al. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 748-752.
84. Guo SS, Huang C, Maynard LM et al. Body mass index during childhood, adolescence and young adulthood in relation to adult overweight and adiposity: the Fels Longitudinal Study. Int J Obes Relat Metab Disord 2000; 24: 1628-1635.
85. Kvaavik E, Tell GS, Klepp KI. Predictors and tracking of body mass index from adolescence into adulthood: follow-up of 18 to 20 years in the Oslo Youth Study. Arch Pediatr Adolesc Med 2003; 157: 1212-1218.
86. Yang X, Telama R, Leskinen E et al. Testing a model of physical activity and obesity tracking from youth to adulthood: the cardiovascular risk in young Finns study. Int J Obes (Lond) 2007; 31: 521-527.
87. Herman KM, Craig CL, Gauvin L, Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: the Physical Activity Longitudinal Study. Int J Pediatr Obes 2009; 4: 281-288.
88. Soric M, Jembrek GM, Gostovic M et al. Tracking of BMI, fatness and cardiorespiratory fitness from adolescence to middle adulthood: the Zagreb Growth and Development Longitudinal Study. Ann Hum Biol 2014; 41: 238-243.
89. Yang HP, Wentzensen N, Trabert B et al. Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol 2013; 177: 142-151.
90. Setiawan VW, Yang HP, Pike MC et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607-2618.
91. Rimm EB, Stampfer MJ, Colditz GA et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990; 1: 466-473.